Saturday, June 19, 2021 10:51:42 AM
Thoughts??
November 3, 2020 post
For the past 12 weeks Annelise has been a participant on the Anavex 2-73 double blind placebo clinical drug trial. We are not aware if Annelise was receiving the drug or the placebo but today I can confirm Annelise has had her first dose of the clinical trial drug.
She will now participate In a 48 week open label study. That means 48 weeks on the actual drug.
June 18, 2021 post
Annelise spent last night wired up for a Video EEG in the Epilepsy monitoring unit at Westmead Children's Hospital. We have been concerned by her nocturnal seizures that have been waking her from sleep. Annelise had a seizure before leaving home. On admission she was wired up and soon after had another seizure. Not long after dad had settled her for the night and she had drifted off to sleep, once again a seizure disrupted her slumber. This was captured and as you can see in the photos, how much a 10 second seizure affects our girls brainwaves. Imagine having these all the time, every day/night. Seizures leave us all feeling helpless as we never know when they will strike and there is nothing we can do once they do. We have to just ride it out along with our girl.
Some girls with Rett have hundreds a day.
Our girl is back home, her hair washed to remove all the glue, but she is not herself she is still recovering from a rough night. She was in no mood for photos or snapchat.
November 3, 2020 post
For the past 12 weeks Annelise has been a participant on the Anavex 2-73 double blind placebo clinical drug trial. We are not aware if Annelise was receiving the drug or the placebo but today I can confirm Annelise has had her first dose of the clinical trial drug.
She will now participate In a 48 week open label study. That means 48 weeks on the actual drug.
June 18, 2021 post
Annelise spent last night wired up for a Video EEG in the Epilepsy monitoring unit at Westmead Children's Hospital. We have been concerned by her nocturnal seizures that have been waking her from sleep. Annelise had a seizure before leaving home. On admission she was wired up and soon after had another seizure. Not long after dad had settled her for the night and she had drifted off to sleep, once again a seizure disrupted her slumber. This was captured and as you can see in the photos, how much a 10 second seizure affects our girls brainwaves. Imagine having these all the time, every day/night. Seizures leave us all feeling helpless as we never know when they will strike and there is nothing we can do once they do. We have to just ride it out along with our girl.
Some girls with Rett have hundreds a day.
Our girl is back home, her hair washed to remove all the glue, but she is not herself she is still recovering from a rough night. She was in no mood for photos or snapchat.
Recent AVXL News
- Form 8-K - Current report • Edgar (US Regulatory) • 05/22/2026 12:15:26 PM
- Anavex Life Sciences Receives Expected Nasdaq Delinquency Notification • GlobeNewswire Inc. • 05/22/2026 12:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/15/2026 08:15:25 PM
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 05/14/2026 08:15:30 PM
- Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB • Edgar (US Regulatory) • 05/11/2026 08:30:22 PM
- CEO Transition and Delayed SEC Filing Put Anavex (AVXL) Leadership Changes in Focus • IH Market News • 05/06/2026 02:52:36 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/06/2026 11:04:59 AM
- Anavex Life Sciences Board of Directors Appoints Former Senior Vice President of Clinical Development Terrie Kellmeyer, PhD, as Interim Chief Executive Officer • GlobeNewswire Inc. • 05/06/2026 11:00:00 AM
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 05/01/2026 11:18:47 PM
- Anavex Life Sciences Highlights New Scientific Findings on Shared Biology Between Autism and Alzheimer’s Disease • GlobeNewswire Inc. • 04/14/2026 11:30:00 AM
- Anavex Life Sciences to Present at the 25th Annual Needham Virtual Healthcare Conference • GlobeNewswire Inc. • 04/07/2026 11:30:00 AM
- Anavex withdraws EU approval filing for Alzheimer’s therapy • IH Market News • 03/30/2026 12:39:26 PM
- Anavex Life Sciences Provides Comprehensive Regulatory Update • GlobeNewswire Inc. • 03/30/2026 11:30:00 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/25/2026 08:06:00 PM
- Anavex withdraws EU marketing application for Alzheimer’s therapy blarcamesine • IH Market News • 03/25/2026 02:06:58 PM
- Anavex Life Sciences Provides Update on Regulatory Review in the EU for Blarcamesine to Treat Early Alzheimer’s Disease • GlobeNewswire Inc. • 03/25/2026 11:30:00 AM
- Anavex Life Sciences Presents New Data from its AD-004 Phase IIb/III Trial at AD/PD 2026 Conference Demonstrating Consistent Correlation Between the Treatment Effect of Oral Blarcamesine and Preservation of Brain Volume in Early Alzheimer’s Disease • GlobeNewswire Inc. • 03/23/2026 11:30:00 AM
- New Scientific Findings Highlight Hypothesis of Autophagy Failure as a Precursor of Amyloid Beta and Tau Pathology in Alzheimer’s Disease • GlobeNewswire Inc. • 03/20/2026 11:30:00 AM
- Anavex Life Sciences Presents Significant Treatment Effects of Blarcamesine in New Advanced Alpha-Synuclein Model of Parkinson’s Disease at AD/PD 2026 Conference • GlobeNewswire Inc. • 03/17/2026 11:30:00 AM
- Anavex Life Sciences to Present at the Citizens Life Sciences Conference • GlobeNewswire Inc. • 03/03/2026 12:30:00 PM
- Anavex Life Sciences to Present at the 46th TD Cowen Annual Health Care Conference • GlobeNewswire Inc. • 02/25/2026 12:30:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/25/2026 11:07:01 AM
- Anavex Life Sciences Appoints Seasoned Healthcare Leader to Board of Directors • GlobeNewswire Inc. • 02/23/2026 12:30:00 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 02/09/2026 09:40:27 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/09/2026 12:31:17 PM
